Partner Article
Northwich-based Dechra Pharmaceuticals PLC remains ‘confident’
Competitor stock shortages in the US have meant strong revenues for Northwich-based Dechra Pharmaceuticals.
The manufacturer of veterinary products has reported that group revenue has increased in this quarter by 14.3% at constant exchange rates and 6% at actual exchange rates.
The European part of the business has seen revenues fall at actual exchange rates by 3.3% however sales were positively impacted by wholesalers buying in advance of Easter.
The company said: “ We remain on track to deliver our strategic milestones and further progress has been made in the period“
This was posted in Bdaily's Members' News section by Sophia Taha .
Our Partners
Navigating the messy middle of business growth
We must make it easier to hire young people
Why community-based care is key to NHS' future
Culture, confidence and creativity in the North East
Putting in the groundwork to boost skills
£100,000 milestone drives forward STEM work
Restoring confidence for the economic road ahead
Ready to scale? Buy-and-build offers opportunity
When will our regional economy grow?
Creating a thriving North East construction sector
Why investors are still backing the North East
Time to stop risking Britain’s family businesses